Cyrus Capital Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Cyrus Capital Partners’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-200,000	Closed	-$100K	–	23
2014 Q2	$100K	Hold	200,000	–	–	0.01%	21
2014 Q1	$62K	Buy	+200,000	New	+$74.3K	0.01%	19

Other funds holding GCVRZ

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

Allianz Asset Management

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Cyrus Capital Partners's GCVRZ Position: Q3 2014 in Review

Cyrus Capital Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2014, closing a stake of 200,000 shares — an estimated $100K sold.

Cyrus Capital Partners first reported a position in GCVRZ in Q1 2014 and held it in 2 quarters. The position peaked at $100K in Q2 2014. 118 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2014.

Cyrus Capital Partners reported no remaining Sanofi Contingent Value Rights position as of Q3 2014 after selling out during the quarter.
Cyrus Capital Partners sold 200,000 Sanofi Contingent Value Rights shares in Q3 2014, an estimated $100K.
Cyrus Capital Partners first reported a position in Sanofi Contingent Value Rights in Q1 2014 and held it in 2 quarters.
Cyrus Capital Partners's Sanofi Contingent Value Rights position peaked at $100K in Q2 2014.
118 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2014.

Based on Cyrus Capital Partners's 13F filing for Q3 2014, filed 14 Nov 2014.